University of California San Francisco
Helen Diller Family Comprehensive Cancer Center

Hematopoietic Malignancies Program Research Retreat

February 14, 2018, 9:00 am – 12:00 pm

Parnassus
HSW-301

9:00 - 9:15 am

Welcome and Program Overview

Tom Martin, MD

9:15 - 9:45 am

Hyun Yong Jin, PhD

Title: Metabolic Dysregulation in B cell lymphomagenesis

9:45 - 10:15 am

Andreadis Charalambos, MD

Title: TBA

10:15 - 10:45 am Break
10:35 - 10:50 am

Greg Coffey, PhD, Director of Pharmacology and Biology at Portola Pharmaceuticals

Title: Overview of Cerdulatinib, a Novel SYK-JAK Inhibitor: Rational for Development in B and T Cell Malignancies and Initial Phase 1/2 Results

10:50 - 11:20 am

Weiyun Ai, MD, PhD

Title: TBA

11:20 - 11:50 am

JJ Miranda, PhD

Title: Epigenetic Inhibition of EBV-Associated Malignancies

11:50 - 12:00 pm

Program Meeting Updates

Tom Martin, MD

 


Contact Information

Contact
Bao.Sit@ucsf.edu

See more events